Innerer Wert von S&P & Nasdaq Kontaktieren

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Conformis, Inc. (CFMS) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Billerica, MA, United States. Der aktuelle CEO ist Mark A. Augusti.

CFMS hat IPO-Datum 2015-07-01, 295 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $17.88M.

Über Conformis, Inc.

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

📍 600 Technology Park Drive, Billerica, MA 01821 📞 781 345 9001
Unternehmensdetails
SektorGesundheitswesen
BrancheMedical - Devices
LandUnited States
BörseNASDAQ Capital Marke
WährungUSD
IPO-Datum2015-07-01
CEOMark A. Augusti
Mitarbeiter295
Handelsinformationen
Aktueller Kurs$2.27
Marktkapitalisierung$17.88M
52-Wochen-Spanne1.05-7.25
Beta1.42
ETFNein
ADRNein
CUSIP20717E101
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden